Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

11Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Neoadjuvant chemotherapy (NAC) is increasingly widely used in breast cancer treatment, and accurate evaluation of its response provides essential information for treatment and prognosis. Thus, the imaging tools used to quantify the disease response are critical in evaluating and managing patients treated with NAC. We discussed the recent progress, advantages, and disadvantages of common imaging methods in assessing the efficacy of NAC for breast cancer.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

75366Citations
N/AReaders
Get full text

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

23352Citations
N/AReaders
Get full text

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

1502Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Silicon switch: Carbon–silicon Bioisosteric replacement as a strategy to modulate the selectivity, physicochemical, and drug-like properties in anticancer pharmacophores

24Citations
N/AReaders
Get full text

Invasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology Concordance

19Citations
N/AReaders
Get full text

Abbreviated Versus Full-Protocol MRI for Breast Cancer Neoadjuvant Chemotherapy Response Assessment: Diagnostic Performance by General and Breast Radiologists

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kong, X., Zhang, Q., Wu, X., Zou, T., Duan, J., Song, S., … Li, Z. (2022, May 20). Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.816297

Readers over time

‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

36%

Researcher 4

36%

Lecturer / Post doc 2

18%

Professor / Associate Prof. 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

63%

Engineering 4

25%

Nursing and Health Professions 1

6%

Agricultural and Biological Sciences 1

6%

Save time finding and organizing research with Mendeley

Sign up for free
0